mHealth Apps Market Overview
“The mHealth Apps Market is estimated to increase at a CAGR of 12.78% from $ 39.56 billion in 2023 to $ 108.56 Billion by 2030.”
mHealth Apps offer real-time monitoring and self-management for health information sharing, but they are vulnerable to cyber threats due to privacy concerns, data security regulations, and hacking. Market expansion is hindered by lack of digital infrastructure, technological barriers, and fewer governmental approvals for mHealth apps, particularly in emerging nations with limited digital infrastructure and technological barriers. These factors are expected to limit market growth.
Mobile health (mHealth) is rapidly replacing traditional healthcare practices, offering faster and more convenient services. Its primary benefit is quicker and less expensive diagnoses, as well as improved methodology and quality of healthcare services. The market for mHealth apps is rapidly developing, offering flexible alternatives for carers and patients. Healthcare organizations should prioritize mHealth apps to improve their bottom line and enhance patient care. Many people use their phones for health-related activities, such as providing images to doctors.
mHealth technology is crucial in integrated healthcare solutions, as over 80% of organizations use it. Doctors agree that mobile medical apps can improve patient health, reduce office visits, and enhance data efficiency. Most healthcare organizations also believe that incorporating mHealth technology can improve data efficiency and reduce the need for office visits.
The impact of COVID-19 on the market has been significant and varied.
The COVID-19 pandemic has significantly impacted the mobile health app market, with both government and non-government groups encouraging its use for contact tracking, remote monitoring, self-management of symptoms, and pandemic control training. The growth of mHealth Apps also includes patients with chronic illnesses who transitioned to digital consultations to prevent physical visits from spreading.
>>>Download Sample Report Now: https://marketreportservice.com/request-sample/mhealth-apps-market-54496
mHealth Apps Market Segment Analysis
In 2022, the applications sector had a commanding 83.45% market share in the worldwide mHealth market. This is a result of both the aggressive marketing through digital media and the rising number of mHealth firms. The social media was essential in raising awareness of the mHealth applications, which accelerated uptake over the previous few years. The expansion of this market is anticipated to pick up steam in the years to come due to increasing internet usage and a rise in smartphone users. Additionally, the mHealth applications may have a favourable influence on treatment and health outcomes. The mHealth can aid in managing and storing patient care and health-related information.
The wearables market is expected to rapidly grow due to the growing popularity of wearable technology for fitness and health purposes, driven by the increasing popularity of smart watches and fit-bits, which are expected to drive this growth.
The market for monitoring services is expected to grow significantly due to the rise in chronic diseases and the increasing mortality rate and prevalence of these illnesses. The Chinese population is experiencing a significant public health concern due to the rising proportion of chronic conditions, rising treatment costs, and longer recovery periods. The State Council Information Office reports that around 260 million individuals are diagnosed with chronic diseases annually, highlighting the need for improved access to monitoring services and treatment options.
Market Dynamics
Drivers
Chronic conditions, which require constant monitoring and routine checkups, significantly impact the market share of mHealth Apps. The market development is driven by new technologies and the growing demand for efficient mHealth solutions. The expansion is driven by cost reduction, patient engagement, and digital-centric care delivery. The demand for high-quality health apps is projected to grow, with 3,50,000 available on the app store, according to IQVIA.
Patients receive health information, treatment compliance, and medical appointments through phone calls, text messages, and voicemails. Healthcare workers have access to tools for peer interaction, data analysis, diagnostic support, and client connections. SMS notifications have a greater influence on behavior than radio and television advertisements. By bridging the health information gap in developing countries, remote data collecting helps policymakers evaluate public health efforts, allocate resources wisely, and optimize policies and programs.
Restraints
The mHealth market is expected to grow due to the rise in diabetes incidence, with the International Diabetic Federation estimating 90 million people in southeast Asia will have diabetes by 2021, 113 million by 2030, and 151 million by 2045. This growth is driven by the use of linked gadgets and mHealth apps.
Competitive Landscape of the MHealth Apps Market Analysis
- Airstrip technologies
- AstraZeneca PLC
- Abbott Laboratories
- Bristol-Myers Squibb Company
- Pfizer Inc
- Allscripts
- AT&T
- Apple Inc
- Sanofi
- Johnson and Johnson
- Orange
- Google Inc
- Samsung Electric Co. ltd
- Teladoc Health Inc.
- Qualcomm Technologies Inc
- GlaxoSmithKline Plc
- Merck & Co. Inc
- Hoffmann-La Roche Ltd.
- Novartis AG
New Developments in MHealth Apps Market
In Jan 2022, Pfizer has sponsored the MyCancerGuide App for fast-tracking the adoption of telehealth globally. This app would facilitate the early detection of breast and cervical cancer.
In Jan 2022, a joint partnership of BrightInsight and Sanofi was announced to bring to the market Sanofi's best in class software as a medical device with next generation digital companion application.
March 1, 2022 “Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis”
Novartis has entered into a collaboration with Pear Therapeutics to develop novel prescription digital therapeutics, software applications designed to effectively treat disease and improve clinical outcomes for patients. The collaboration brings together Novartis expertise in biomedical research and clinical development with Pear's leading experience in digital therapeutics design and implementation.
March 05, 2023- mHealth is more than just a buzz word for Allscripts at HIMSS13 this week. The EHR giant took the opportunity to announce the winners of its Open App Challenge, a chance for mobile developers to “start a revolution” by creating innovative stand-alone mHealth apps that can integrate into Allscripts’ EHR offerings. Each of the 15 winners will receive a $150,000 prize for apps that allow patients to interact with physicians and take charge of their own healthcare through their ubiquitous smartphones and tablets.
Regional Analysis of Global MHealth Apps Industry
“The market is driven by various factors, including economic conditions, political climate, and consumer preferences.”
The United States holds a significant market share of 33.5% in the global mHealth Apps market, driven by factors like increasing chronic disease frequency, improved network coverage, and increased awareness among the population about the benefits of mobile health applications.
“The study aims to identify which countries are expected to provide the most significant market opportunities.”
China is predicted to dominate the mHealth Apps market with a CAGR of 17.56%, followed by Canada at 14.5%, Germany at 12.8%, Japan, and the UK at 13.2%. These markets are expanding faster due to reduced base effects and potential clients.
Segments Covered in the MHealth Apps Market Report
By Product Type
- Medical Apps
- Women’s Health Apps
- Personal Health Record Apps
- Medication Management Apps
- Diagnostic Apps
- Remote Monitoring Apps
- Disease Management Apps
- Other Medical Apps
- Fitness Apps
- Diet & Nutrition
- Exercise & Fitness
- Lifestyle & Stress
By Region type
- North America
- Latin America
- Europe
- APAC
- MEA
Frequently Asked Questions
What is the expected growth rate of the MHealth Apps market over the next 7 years?
mHealth Apps Market is estimated to increase at a CAGR of 12.78% from $ 39.56 billion in 2023 to $ 108.56 Billion by 2030| Report 2023 by published by Market Report Service.
Who are the major players in the MHealth Apps market and what is their market share?
Airstrip technologies, AstraZeneca PLC, Abbott Laboratories, Bristol-Myers Squibb Company, Pfizer Inc, Allscripts, AT&T, Apple Inc, Sanofi, Johnson and Johnson, Orange, Google Inc, Samsung Electric Co. ltd, Teladoc Health Inc., Qualcomm Technologies Inc, GlaxoSmithKline Plc, Merck & Co. Inc, F. Hoffmann-La Roche Ltd., Novartis AG, are prominent players operating and dominating in the market.
Who are the top 3 MHealth Apps Market Key Vendors?
Airstrip technologies, AstraZeneca PLC, Abbott Laboratories, are key players in the MHealth Apps market.
Which geographical areas dominate the worldwide market for MHealth Apps?
Europe region are emerging as the top regional markets for MHealth Apps solutions.
1.SUMMARY
1.1. MHealth Apps Market Overview
1.2. Key Insights
1.3. Report Scope
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
- DECISION-MAKING SUMMARY
- INTRODUCTION
3.1. Overview of MHealth Apps
3.2. Key Historical Events
3.3. Structure
3.4. Biochemical Interaction
3.5. Target Indications
3.6. Advantages of MHealth Apps
3.7 Challenges associated with MHealth Apps
3.8. Future Perspectives.
- MARKET LANDSCAPE
4.1. Methodology
4.2 MHealth Apps: Developer Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters (Region-wise)
4.2.4. Analysis by Location of Headquarters (Country-wise)
4.2.5. Analysis by Year of Establishment, Company Size and Location of Headquarters (Region-wise)
4.2.6. Most Active Players
- COMPANY
5.1. Company Overview
5.1.2 Management Team
5.1.3. Product Portfolio
5.1.4. Recent Developments and Future Outlook
- PARTNERSHIPS AND COLLABORATIONS
6.1. Partnership Models
6.2. MHealth Apps: Partnerships and Collaborations
6.2.1. Analysis by Year of Partnership
6.2.2. Analysis by Type of Partnership
6.2.3. Analysis by Year and Type of Partnership
6.2.4. Analysis by Type of Partner
6.2.5. Analysis by Year of Partnership and Type of Partner
6.2.6. Analysis by Type of Partnership and Type of Partner
6.2.7. Analysis by Type of Partner and Parent Company Size
- ACADEMIC GRANTS ANALYSIS
7.1. Methodology and Key Parameters
7.2. MHealth Apps: Academic Grants Analysis
7.2.1. Analysis by Year of Grant Award
7.2.2. Analysis by Amount Awarded
7.2.3. Analysis by Funding Institute Center
7.2.4. Analysis by Support Period
7.2.5. Analysis by Funding Institute Center and Support Period
7.2.6. Analysis by Type of Grant Application
7.2.7. Analysis by Purpose of Grant
- PUBLICATION ANALYSIS
8.1. Analysis Methodology and Key Parameters
8.2. MHealth Apps: Publication Analysis
8.2.1. Analysis by Year of Publication
8.2.2. Analysis by Type of Publication
8.2.3. Analysis by Type of Conjugate
8.2.4. Analysis by Target Indication
8.2.5. Analysis by Copyright Holder
8.2.6. Word Cloud: Emerging Focus Area
8.2.7. Most Active Publishers: Analysis by Number of Publications
- SUCCESS PROTOCOL ANALYSIS
9.1. Methodology and Key Parameters
9.2. Key Assumptions and Scoring Criteria
9.3. Success Protocol Analysis
9.4. Assessment of Approved MHealth Apps
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies
- Airstrip technologies
- AstraZeneca PLC
- Abbott Laboratories
- Bristol-Myers Squibb Company
- Pfizer Inc
- Allscripts
- AT&T
- Apple Inc
- Sanofi
- Johnson and Johnson
- Orange
- Google Inc
- Samsung Electric Co. ltd
- Teladoc Health Inc.
- Qualcomm Technologies Inc
- GlaxoSmithKline Plc
- Merck & Co. Inc
- Hoffmann-La Roche Ltd.
- Novartis AG
